Why the study?
Although exercise improves health outcomes in multiple sclerosis, no standardized, reliable tool existed for functional assessment to inform tailored exercise prescriptions and patient categorization.
Is the MScope battery a reliable tool for assessing functional status in patients with multiple sclerosis?
Is the MScope battery a reliable tool for assessing functional status in patients with multiple sclerosis?
The MScope battery is a highly reliable comprehensive tool for objectively evaluating structural, functional, and neuromuscular status in patients with multiple sclerosis.
MScope reliability data may aid MS assessment; leaves open exercise prescription use pending larger trials.
Multiple sclerosis (MS) is a neurodegenerative disease that often leads to severe disability. Although exercise, particularly strength training, improves health outcomes in MS, no standardized, reliable tool exists for functional assessment to inform tailored exercise prescriptions and patients’ categorization. This study aimed to validate the reliability of the MScope battery, a comprehensive tool incorporating structural, functional, and neuromuscular assessments to objectively evaluate patients with MS. A reproducibility study was conducted with 40 MS patients who completed the MScope battery twice, 72 h apart. Tests included structural (muscle thickness of the vastus lateralis and rectus femoris), functional (sit-to-stand, timed up-and-go, 10 m and six-minute walking test), and neuromuscular tests (isometric strength during the squat and leg extension exercises and handgrip strength). Intraclass correlation coefficients (ICCs), Bland–Altman plots, and the coefficient of variation (CV) were used to evaluate intra- and inter-day reliability. The MScope battery showed high intra- and inter-day reliability, with ICC values ranging from 0.79 to 0.99. Muscle thickness measurements, along with handgrip strength, demonstrated excellent reliability (ICC > 0.9, CV < 5%). Functional tests, including the timed up-and-go, 10 m walk, and sit-to-stand variations, maintained consistent scores (ICC > 0.85, CV < 10%). The six-minute walking test exhibited excellent inter-day reliability (ICC = 0.94, CV < 4%). Neuromuscular assessments showed strong reliability with minor day-to-day variability (ICC = 0.75–0.95, CV < 8%). The battery’s overall consistency supports its use as a reliable tool for assessing functional status in MS patients.
No takes yet. Share an insight, caveat, or question.
Lisardo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: